← Back to Clinical Trials
Recruiting NCT06924177

NCT06924177 UTSW NORC Pilot Spinal Cord Injury Dietary Program

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06924177
Status Recruiting
Phase
Sponsor University of Texas Southwestern Medical Center
Condition Obesity and Obesity-related Medical Conditions
Study Type INTERVENTIONAL
Enrollment 20 participants
Start Date 2026-02-13
Primary Completion 2027-05-31

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 65 Years
Study Type INTERVENTIONAL
Interventions
Telehealth with dietician

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 20 participants in total. It began in 2026-02-13 with a primary completion date of 2027-05-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this observational study is to learn about the effects of a 9-week dietician-guided program modified from the National Diabetic Prevention Program (modified DPP-diet) in people with spinal cord injury on body composition and insulin sensitivity. The main question it aims to answer is: Does 9 week modified DPP-diet reduce body fat percentage and insulin resistance? Participants will: Have 9 weeks of Telehealth visit with dietician certified in providing DPP. Visit the laboratory before, immediately and 9 weeks after completion of the modified DPP-diet. Share with the researcher on the perceived benefit and obstacles in implementing the modified DPP-diet as part of their daily activities.

Eligibility Criteria

Inclusion Criteria: * age 18-65 years old * have had SCI for more than one year * not independently ambulatory * primarily uses a wheelchair for mobility * community-dwelling * without comorbidities listed in the exclusion criteria Exclusion Criteria: * uncontrolled type 2 diabetes mellitus * pregnancy * active systemic disease, e.g., heart disease, real failure/insufficiency, multiple myeloma, lupus with nephropathy, sickle cell disease, symptomatic myasthenia gravis, poorly controlled hypo- or hyperthyroidism.

Contact & Investigator

Central Contact

Yi-Ting Tzen

✉ Yi-Ting.Tzen@UTSouthwestern.edu

📞 214-648-1786

Frequently Asked Questions

Who can join the NCT06924177 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Obesity and Obesity-related Medical Conditions. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06924177 currently recruiting?

Yes, NCT06924177 is actively recruiting participants. Contact the research team at Yi-Ting.Tzen@UTSouthwestern.edu for enrollment information.

Where is the NCT06924177 trial being conducted?

This trial is being conducted at Dallas, United States.

Who is sponsoring the NCT06924177 clinical trial?

NCT06924177 is sponsored by University of Texas Southwestern Medical Center. The trial plans to enroll 20 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology